Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CADL Candel Therapeutics
2.420+0.080+3.42%
Close
02/03 16:00 ET
2.4350.0000.00%
Post Mkt Price 02/03 16:00 ET
High
2.520
Open
2.510
Turnover
34.76K
Low
2.350
Pre Close
2.340
Volume
14.47K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
12 Health Care Stocks Moving In Monday's Intraday Session
GainersJaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100
Candel Therapeutics, Inc. (NASDAQ:CADL) Sees Significant Decline in Short Interest
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Rating) was the recipient of a significant drop in short interest in the month of December. As of December 30th, there was short interest totalling 30,700
Fennec Pharmaceuticals (NASDAQ:FENC) Versus Candel Therapeutics (NASDAQ:CADL) Critical Comparison
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) and Candel Therapeutics (NASDAQ:CADL – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two b
Candel Therapeutics, Inc. (NASDAQ:CADL) Sees Significant Growth in Short Interest
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Rating) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 51,000 shares, an increase of 38.6% f
Candel Therapeutics, Inc. (NASDAQ:CADL) Short Interest Up 38.6% in December
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 51,0
Stocks That Hit 52-Week Lows On Tuesday
 Tuesday's session saw 325 companies set new 52-week lows. 52-Week Low Highlights: Apple (NASDAQ:AAPL) was the biggest company in terms of market cap to set a new 52-week low.InMed Pharmaceuticals
Comparing Genfit (NASDAQ:GNFT) & Candel Therapeutics (NASDAQ:CADL)
Genfit (NASDAQ:GNFT – Get Rating) and Candel Therapeutics (NASDAQ:CADL – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on t
Candel Therapeutics, Inc. (NASDAQ:CADL) Sees Large Drop in Short Interest
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Rating) was the target of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 36,800 shares, a
12 Health Care Stocks Moving In Friday's After-Market Session
GainersCardio Diagnostics Hldgs (NASDAQ:CDIO) shares moved upwards by 41.7% to $1.46 during Friday's after-market session. The company's market cap stands at $13.8 million. Akili (NASDAQ:AKLI) shares
UBS Adjusts Candel Therapeutics Price Target to $8 From $11, Maintains Buy Rating
09:39 AM EST, 12/09/2022 (MT Newswires) -- Candel Therapeutics (CADL) has an average rating of Outperform and price targets ranging from $8 to $22, according to analysts polled by Capital IQ. (MT News
Company Overview
More
Candel Therapeutics, Inc. operates as a biopharmaceutical company that develops and commercializes cancer immunotherapy drugs. It offers aglatimagene besadenovec (CAN-2409), a replication-deficient adenovirus that delivers within infected cancer cells the herpes simplex virus thymidine kinase (HSV-tk) gene. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
CEO： Dr. Paul Peter Tak, M.D.,PhD
Market： NASDAQ
Listing Date： 07/27/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet